Enanta Pharmaceuticals (ENTA) Cash from Investing Activities Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.05% |
| Dec 31, 2025 | -22.08% |
| Sep 30, 2025 | -1.72% |
| Jun 30, 2025 | -24.48% |
| Mar 31, 2025 | -16.62% |
| Dec 31, 2024 | 30.96% |
| Sep 30, 2024 | 18.79% |
| Jun 30, 2024 | 15.64% |
| Mar 31, 2024 | 113.49% |
| Dec 31, 2023 | 8.92% |
| Sep 30, 2023 | 28.39% |
| Jun 30, 2023 | -35.88% |
| Mar 31, 2023 | 48.59% |
| Dec 31, 2022 | 73.48% |
| Sep 30, 2022 | 31.25% |
| Jun 30, 2022 | 16.19% |
| Mar 31, 2022 | -84.55% |
| Dec 31, 2021 | 120.90% |
| Sep 30, 2021 | 69.09% |
| Jun 30, 2021 | -6.82% |
| Mar 31, 2021 | 125.03% |
| Dec 31, 2020 | -25.37% |
| Sep 30, 2020 | -9.38% |
| Jun 30, 2020 | 26.79% |
| Mar 31, 2020 | 17.69% |
| Dec 31, 2019 | -48.80% |
| Sep 30, 2019 | -50.29% |
| Jun 30, 2019 | 11.48% |
| Mar 31, 2019 | -40.17% |
| Dec 31, 2018 | -77.29% |
| Sep 30, 2018 | -0.80% |
| Jun 30, 2018 | 8.19% |
| Mar 31, 2018 | 19.21% |
| Dec 31, 2017 | -24.40% |
| Sep 30, 2017 | -29.29% |
| Jun 30, 2017 | 21.00% |